Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19

18 Jun 2021

Abstract excerpt

Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that govern the pathophysiology of different disease courses remain poorly defined. Across the spectrum of disease severity, COVID-19 impairs both innate and adaptive host immune responses by activating innate immune cell recruitment, while resulting in low lymphocyte counts. Recently, several reports have shown that patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune cells in cancer
Share to Inflammation biomarkers and pathways
Share to Inflammatory Biomarkers in Disease Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34220859
DOI: 10.3389/fimmu.2021.697405

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19PMID 34220859Read ↗

Deciphering the state of immune silence in fatal COVID-19 patientsSemantic proximity Read ↗

Deciphering the state of immune silence in fatal COVID-19 patientsSemantic proximity Read ↗

Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19Semantic proximity Read ↗

Analysis of respiratory and systemic immune responses in COVID-19 reveals mechanisms of disease pathogenesisSemantic proximity Read ↗

A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signalingSemantic proximity Read ↗

Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patientsSemantic proximity Read ↗

Myeloid-derived suppressor cells in COVID-19: A reviewSemantic proximity Read ↗

Bronchoalveolar Lavage Single-Cell Transcriptomics Identifies Immune Cells Driving COVID-19 Severity in PatientsSemantic proximity Read ↗

Innate immune deficiencies in patients with COVID-19Semantic proximity Read ↗

MDSCs IN COVID-19 Why should we care?Semantic proximity Read ↗

Patients with moderate to severe COVID-19 have an impaired cytokine response with an exhausted and senescent immune phenotype.Semantic proximity Read ↗

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.